Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430254 · ClinicalTrials.gov registry record
Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 88
- Enrollment target
NCT07430254: Clinical Trial study, sponsored by Stanford University.
NCT07430254 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07430254 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 88 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine whether noninvasive finger plethysmographic cardiac output monitoring can help predict fluid responsiveness in pregnant women, including those with preeclampsia with severe features. The main questions it aims to answer are : * Can changes in cardiac output measured by finger plethysmography predict fluid responsiveness? * How does this method perform compared with standard echocardiographic assessment? Participants will provide consent and undergo noninvasive hemodynamic monitoring and a brief reversible physiological challenge.
Primary Outcome
Prediction accuracy (ROC-AUC) of percent change in cardiac output measured by noninvasive finger plethysmographic device during passive leg raising to identify fluid responsiveness (TTE reference)
Interventions
- DIAGNOSTIC_TEST Noninvasive finger plethysmographic cardiac output monitoring
- DIAGNOSTIC_TEST Standard transthoracic echocardiographic assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-01 |
What is known before NCT07430254 opens enrollment
NCT07430254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Noninvasive finger plethysmographic cardiac output monitoring is the first listed.
NCT07430254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07430254 about?
NCT07430254 is a clinical study titled "Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia". The goal of this observational study is to determine whether noninvasive finger plethysmographic cardiac output monitoring can help predict fluid responsiveness in pregnant women, including those with preeclampsia with severe features. The main questions it aims to answer are : * Can changes in ca...
What is the current status of trial NCT07430254?
This trial is currently not yet recruiting. The enrollment target is 88 participants. The study started on 2026-07-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07430254?
The interventions under investigation include: Noninvasive finger plethysmographic cardiac output monitoring (DIAGNOSTIC_TEST), Standard transthoracic echocardiographic assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07430254?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI